PRSS3 Gene

HGNC Family Proteases, serine (PRSS)
Name protease, serine, 3
Description This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is expressed in the brain and pancreas and is resistant to common trypsin inhibitors. It is active on peptide linkages involving the carboxyl group of lysine or arginine. This gene is localized to the locus of T cell receptor beta variable orphans on chromosome 9. Four transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2010]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPRSS3, also known as mesotrypsin or trypsin‐4, is a unique serine protease that diverges from canonical trypsin isoforms by exhibiting marked resistance to standard trypsin inhibitors and an unusual substrate specificity. Detailed biochemical and structural studies have revealed that single amino acid substitutions—such as the replacement of a conserved glycine with arginine—endow PRSS3 with the capacity to degrade protein inhibitors (e.g., Kunitz‐type inhibitors) while sparing normal zymogen activation pathways. Kinetic and thermodynamic analyses further demonstrated that PRSS3’s reactivity is characterized by the selective cleavage of specific peptide bonds in substrates such as α₁‐antitrypsin and the Kunitz domain of amyloid precursor protein, thereby modulating its inhibitory interactions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the oncologic context, aberrant expression of PRSS3 has been linked to tumor progression, metastasis, and therapeutic resistance in a wide array of human cancers. Multiple studies document that either over‐expression or epigenetic silencing (via promoter hypermethylation) of PRSS3 correlates with aggressive disease features and poor patient prognosis in malignancies including bladder, pancreatic, breast, lung, colon, ovarian, and hepatocellular carcinomas. Notably, PRSS3 has been implicated in driving malignant cell growth and invasion by activating protease‐activated receptors (PARs), modulating matrix degradation, and even cleaving therapeutic antibodies such as cetuximab, thereby contributing to drug resistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its oncogenic roles, PRSS3 is expressed in normal tissues where it participates in key physiological processes. In neural and epithelial compartments, including the brain and skin, mesotrypsin is involved in regulating proteolytic cascades that influence cell differentiation, barrier formation, and inflammatory responses. For instance, its localized expression in neurons, glial cells, and the epidermal granular layer supports a role in neural function and keratinocyte terminal differentiation, while genetic variants of PRSS3 have been associated with heightened susceptibility to pancreatitis by promoting the degradation of endogenous trypsin inhibitors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, recent investigations have underscored the potential of targeting PRSS3 for therapeutic gain. Owing to its capacity to cleave protective inhibitors and even therapeutic monoclonal antibodies, selective inhibition of mesotrypsin is emerging as a promising strategy to counteract metastasis and overcome drug resistance, as well as to mitigate aberrant proteolytic activity in infectious or inflammatory settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "36", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Gergely Katona, Gunnar I Berglund, Janos Hajdu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure reveals basis for the inhibitor resistance of human brain trypsin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/jmbi.2001.5305"}], "href": "https://doi.org/10.1006/jmbi.2001.5305"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11827488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11827488"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Richárd Szmola, Zoltán Kukor, Miklos Sahin-Tóth "}, {"type": "b", "children": [{"type": "t", "text": "Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M310301200"}], "href": "https://doi.org/10.1074/jbc.M310301200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14507909"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14507909"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Péter Medveczky, József Antal, András Patthy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2005.12.067"}], "href": "https://doi.org/10.1016/j.febslet.2005.12.067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16412431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16412431"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Júlia Tóth, Linda Gombos, Zoltán Simon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thermodynamic analysis reveals structural rearrangement during the acylation step in human trypsin 4 on 4-methylumbelliferyl 4-guanidinobenzoate substrate analogue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M512301200"}], "href": "https://doi.org/10.1074/jbc.M512301200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16492676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16492676"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Edit Szepessy, Miklós Sahin-Tóth "}, {"type": "b", "children": [{"type": "t", "text": "Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2006.05305.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2006.05305.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16759229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16759229"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wolfgang Knecht, Graeme S Cottrell, Silvia Amadesi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M703840200"}], "href": "https://doi.org/10.1074/jbc.M703840200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17623652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17623652"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Moh'd A Salameh, Jessica L Robinson, Duraiswamy Navaneetham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.057216"}], "href": "https://doi.org/10.1074/jbc.M109.057216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19920152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19920152"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Alexandre P Alloy, Olumide Kayode, Ruiying Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.662429"}], "href": "https://doi.org/10.1074/jbc.M115.662429"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26175157"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26175157"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Carmen J Marsit, Margaret R Karagas, Hadi Danaee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Carcinogen exposure and gene promoter hypermethylation in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgi172"}], "href": "https://doi.org/10.1093/carcin/bgi172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15987713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15987713"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Carmen J Marsit, Chinedu Okpukpara, Hadi Danaee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.20125"}], "href": "https://doi.org/10.1002/mc.20125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16013053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16013053"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "A P M Kerckhoffs, J J M Ter Linde, L M A Akkermans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogastroenterol Motil (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2982.2008.01100.x"}], "href": "https://doi.org/10.1111/j.1365-2982.2008.01100.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18363639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18363639"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Alexandra Hockla, Derek C Radisky, Evette S Radisky "}, {"type": "b", "children": [{"type": "t", "text": "Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-009-0699-0"}], "href": "https://doi.org/10.1007/s10549-009-0699-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20035377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20035377"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Guozhong Jiang, Fengyu Cao, Guoping Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRSS3 promotes tumour growth and metastasis of human pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gut (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/gut.2009.200105"}], "href": "https://doi.org/10.1136/gut.2009.200105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20947888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20947888"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ruiqiong Ma, Xue Ye, Hongyan Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gynecol Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ygyno.2015.02.022"}], "href": "https://doi.org/10.1016/j.ygyno.2015.02.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25735255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25735255"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Bonan Lin, Xiaomeng Zhou, Shuye Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-017-1578-5"}], "href": "https://doi.org/10.1007/s00109-017-1578-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28844099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28844099"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Honghai Ma, Alexandra Hockla, Christine Mehner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-38362-0"}], "href": "https://doi.org/10.1038/s41598-018-38362-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30755669"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30755669"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Fei Wang, Yi-Lin Hu, Ying Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Surg Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jso.25448"}], "href": "https://doi.org/10.1002/jso.25448"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30908656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30908656"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Chenju Xing, Hua Ye, Weiwei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Artif Cells Nanomed Biotechnol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21691401.2019.1671856"}], "href": "https://doi.org/10.1080/21691401.2019.1671856"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31810373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31810373"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Zhaoli Tan, Lihua Gao, Yan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRSS contributes to cetuximab resistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Adv (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/sciadv.aax5576"}], "href": "https://doi.org/10.1126/sciadv.aax5576"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31911942"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31911942"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Quanyi Zhang, Jihai Wang, Di Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High Expression of PRSS3 Indicates Unfavorable Clinical Outcomes in Colon Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000921"}], "href": "https://doi.org/10.1097/PAI.0000000000000921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33758142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33758142"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Soulaimane Aboulouard, Maxence Wisztorski, Marie Duhamel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.xcrm.2021.100318"}], "href": "https://doi.org/10.1016/j.xcrm.2021.100318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34195683"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34195683"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Liangda Zheng, Xianting Wang, Weizhi Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serine Protease 3 Promotes Progression of Diffuse Large B-Cell Lymphoma and Serves as a Novel Prognostic Predictor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/1254790"}], "href": "https://doi.org/10.1155/2022/1254790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36618965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36618965"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Muya Zhou, Koukou Li, Kathy Qian Luo "}, {"type": "b", "children": [{"type": "t", "text": "Shear Stress Drives the Cleavage Activation of Protease-Activated Receptor 2 by PRSS3/Mesotrypsin to Promote Invasion and Metastasis of Circulating Lung Cancer Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Sci (Weinh) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/advs.202301059"}], "href": "https://doi.org/10.1002/advs.202301059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37395651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37395651"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Zsófia Nemoda, Niels Teich, Christin Hugenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic and biochemical characterization of the E32del polymorphism in human mesotrypsinogen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreatology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000085282"}], "href": "https://doi.org/10.1159/000085282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15855826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15855826"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Júlia Tóth, Erika Siklódi, Péter Medveczky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurochem Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11064-007-9327-8"}], "href": "https://doi.org/10.1007/s11064-007-9327-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17406981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17406981"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "H Koistinen, R Koistinen, W-M Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nexin-1 inhibits the activity of human brain trypsin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2009.02.042"}], "href": "https://doi.org/10.1016/j.neuroscience.2009.02.042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19249338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19249338"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Jotaro Nakanishi, Mami Yamamoto, Junichi Koyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Keratinocytes synthesize enteropeptidase and multiple forms of trypsinogen during terminal differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2009.364"}], "href": "https://doi.org/10.1038/jid.2009.364"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19924134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19924134"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jonas Rosendahl, Niels Teich, Peter Kovacs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Complete analysis of the human mesotrypsinogen gene (PRSS3) in patients with chronic pancreatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreatology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000243769"}], "href": "https://doi.org/10.1159/000243769"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20484962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20484962"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Hideki Hayashi, Tomoko Kohno, Kiyoshi Yasui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of dsRNA-induced pancreatitis model reveals the regulatory role of IFN regulatory factor 2 (Irf2) in trypsinogen5 gene transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1116273108"}], "href": "https://doi.org/10.1073/pnas.1116273108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22042864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22042864"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Mami Yamamoto-Tanaka, Akira Motoyama, Masashi Miyai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.543421"}], "href": "https://doi.org/10.1074/jbc.M113.543421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24872419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24872419"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Devon Pendlebury, Ruiying Wang, Rachel D Henin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sequence and conformational specificity in substrate recognition: several human Kunitz protease inhibitor domains are specific substrates of mesotrypsin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.609560"}], "href": "https://doi.org/10.1074/jbc.M114.609560"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25301953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25301953"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Carmen Ghilardi, Antonietta Silini, Sara Figini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4949"}], "href": "https://doi.org/10.18632/oncotarget.4949"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26318044"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26318044"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Li Qian, Xiangxiang Gao, Hua Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15590"}], "href": "https://doi.org/10.18632/oncotarget.15590"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28423522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28423522"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Vanda Toldi, András Szabó, Miklós Sahin-Tóth "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA120.012526"}], "href": "https://doi.org/10.1074/jbc.RA120.012526"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32014997"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32014997"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Patthaya Rattanakomol, Potjanee Srimanote, Pongsri Tongtawe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-022-17272-2"}], "href": "https://doi.org/10.1038/s41598-022-17272-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35896602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35896602"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Olumide Kayode, Zunnan Huang, Alexei S Soares, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small molecule inhibitors of mesotrypsin from a structure-based docking screen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0176694"}], "href": "https://doi.org/10.1371/journal.pone.0176694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28463992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28463992"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Hideki Hayashi, Yoshinao Kubo, Mai Izumida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Cell Infect Microbiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fcimb.2018.00091"}], "href": "https://doi.org/10.3389/fcimb.2018.00091"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29629340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29629340"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "András Szabó, Vanda Toldi, Lívia Diána Gazda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defective binding of SPINK1 variants is an uncommon mechanism for impaired trypsin inhibition in chronic pancreatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.100343"}], "href": "https://doi.org/10.1016/j.jbc.2021.100343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33515547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33515547"}]}]}]}
Synonyms PRSS4, T9, MTG
Proteins TRY3_HUMAN
NCBI Gene ID 5646
API
Download Associations
Predicted Functions View PRSS3's ARCHS4 Predicted Functions.
Co-expressed Genes View PRSS3's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View PRSS3's ARCHS4 Predicted Functions.

Functional Associations

PRSS3 has 7,260 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 111 datasets.

Click the + buttons to view associations for PRSS3 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of PRSS3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of PRSS3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of PRSS3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of PRSS3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of PRSS3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of PRSS3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of PRSS3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of PRSS3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with PRSS3 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRSS3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of PRSS3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of PRSS3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of PRSS3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of PRSS3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing PRSS3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing PRSS3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with PRSS3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with PRSS3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of PRSS3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with PRSS3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with PRSS3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with PRSS3 gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with PRSS3 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by PRSS3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DGIdb Drug Targets 2026 interacting drugs for PRSS3 protein from the DGIdb Drug Targets 2026 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with PRSS3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with PRSS3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with PRSS3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with PRSS3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with PRSS3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for PRSS3 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at PRSS3 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRSS3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of PRSS3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing PRSS3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with PRSS3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with PRSS3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of PRSS3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with PRSS3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing PRSS3 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of PRSS3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of PRSS3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of PRSS3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of PRSS3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of PRSS3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of PRSS3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving PRSS3 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving PRSS3 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving PRSS3 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing PRSS3 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing PRSS3 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing PRSS3 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by PRSS3 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by PRSS3 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by PRSS3 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of PRSS3 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of PRSS3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of PRSS3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with PRSS3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with PRSS3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with PRSS3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of PRSS3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for PRSS3 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of PRSS3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of PRSS3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of PRSS3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for PRSS3 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with PRSS3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for PRSS3 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of PRSS3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of PRSS3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways pathways involving PRSS3 protein from the KEGG Pathways dataset.
KEGG Pathways 2026 pathways involving PRSS3 protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of PRSS3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with PRSS3 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of PRSS3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of PRSS3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of PRSS3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of PRSS3 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain PRSS3 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of PRSS3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for PRSS3 from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of PRSS3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for PRSS3 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of PRSS3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving PRSS3 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving PRSS3 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2014 pathways involving PRSS3 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving PRSS3 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of PRSS3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at PRSS3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of PRSS3 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of PRSS3 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of PRSS3 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of PRSS3 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of PRSS3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of PRSS3 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of PRSS3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of PRSS3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of PRSS3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of PRSS3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of PRSS3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with PRSS3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with PRSS3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.